ABC of monitoring drug therapy. Measuring plasma drug concentrations.

ABC of monitoring drug therapy. Measuring plasma drug concentrations.

Bibliographic Details
Main Authors:	Aronson, J, Hardman, M
Format:	Journal article
Language:	English
Published:	1992

Similar Items

ABC of monitoring drug therapy. Why monitor drug therapy?
by: Aronson, J, et al.
Published: (1992)

ABC of monitoring drug therapy. Making the most of plasma drug concentration measurements.
by: Reynolds, D, et al.
Published: (1993)

ABC of monitoring drug therapy. Digoxin.
by: Aronson, J, et al.
Published: (1992)

ABC of monitoring drug therapy. Theophylline.
by: Aronson, J, et al.
Published: (1992)

ABC of monitoring drug therapy. Phenytoin.
by: Aronson, J, et al.
Published: (1992)

ABC of monitoring drug therapy. Patient compliance.
by: Aronson, J, et al.
Published: (1992)

ABC of monitoring drug therapy. Lithium.
by: Aronson, J, et al.
Published: (1992)

ABC of monitoring drug therapy. Cyclosporin.
by: Reynolds, D, et al.
Published: (1992)

ABC of monitoring drug therapy. Aminoglycoside antibiotics.
by: Aronson, J, et al.
Published: (1992)

Monitoring drug therapy.
by: Buclin, T, et al.
Published: (2012)

Monitoring digoxin therapy. The use of plasma digoxin concentration measurements in the diagnosis of digoxin toxicity.
by: Aronson, J, et al.
Published: (1978)

A practical guide to monitoring for adverse drug reactions during antihypertensive drug therapy.
by: McDowell, SE, et al.
Published: (2013)

Drug therapy in kidney disease.
by: Aronson, J
Published: (2007)

Risk perception in drug therapy.
by: Aronson, J
Published: (2006)

ADDED VALUE IN DRUG-THERAPY - INTRODUCTION
by: Aronson, J
Published: (1994)

Monitoring for the Adverse Effects of Drugs
by: Coleman, J, et al.
Published: (2008)

ABC of sleep disorders. Recreational drugs and sleep.
by: Stradling, JR
Published: (1993)

Monitoring digoxin therapy: I. Plasma concentrations and an in vitro assay of tissue response.
by: Aronson, J, et al.
Published: (1977)

Defining rewardable innovation in drug therapy.
by: Aronson, J, et al.
Published: (2012)

Distinguishing hazards and harms, adverse drug effects and adverse drug reactions : implications for drug development, clinical trials, pharmacovigilance, biomarkers, and monitoring.
by: Aronson, J
Published: (2013)

Indications for the measurement of plasma digoxin concentrations.
by: Aronson, J
Published: (1983)

The toxicological significance of post-mortem drug concentrations in bile
by: Ferner, RE, et al.
Published: (2017)

Something new every day: defining innovation and innovativeness in drug therapy.
by: Aronson, J
Published: (2008)

Monitoring therapy.
by: Aronson, J
Published: (2005)

Serious drug interactions.
by: Aronson, J
Published: (1993)

Drugs and renal insufficiency
by: Aronson, J
Published: (2007)

Drugs and renal insufficiency
by: Aronson, J
Published: (2007)

Classifying drug interactions.
by: Aronson, J
Published: (2004)

Beneficial drug interactions.
by: Aronson, J
Published: (1994)

Ribosome protection by ABC‐F proteins — molecular mechanism and potential drug design
by: Ero, Rya, et al.
Published: (2019)

ABC of antithrombotic therapy: An overview of antithrombotic therapy.
by: Blann, A, et al.
Published: (2002)

Drugs for rare disorders
by: Cremers, S, et al.
Published: (2017)

Assessing perceptions of benefit and harm of common drug therapies using therapeutic scenarios
by: Aronson, J, et al.
Published: (2003)

Ethnicity and drug therapy for hypertension
by: Amudha, K., et al.
Published: (2003)

Therapeutic drug monitoring in methadone maintenance therapy (MMT) : an evaluation of genetic factors influencing clinical outcomes and serum concentrations of methadone
by: Mohamed Nazar, Nor Ilyani
Published: (2013)

Monitoring for harms of therapy.
by: Aronson, J
Published: (2006)

Drug therapy of ulcerative colitis.
by: Crotty, B, et al.
Published: (1992)

Modelling drug therapy [filem]
Published: (1977)

Modelling drug therapy [kasetvideo]
Published: (1977)

Rare diseases and orphan drugs.
by: Aronson, J
Published: (2006)